Varshney, K.; Panda, S.; Fernando, H.; Sava, S.; Khan, T.
Impacts of Glucagon-like Peptide-1 Receptor-Agonist (GLP-1 RA) Treatment for Metabolic Disturbances and Weight Gain in Patients on Clozapine/Olanzapine: A Systematic Review. Obesities 2025, 5, 72.
https://doi.org/10.3390/obesities5040072
AMA Style
Varshney K, Panda S, Fernando H, Sava S, Khan T.
Impacts of Glucagon-like Peptide-1 Receptor-Agonist (GLP-1 RA) Treatment for Metabolic Disturbances and Weight Gain in Patients on Clozapine/Olanzapine: A Systematic Review. Obesities. 2025; 5(4):72.
https://doi.org/10.3390/obesities5040072
Chicago/Turabian Style
Varshney, Karan, Shivani Panda, Hilary Fernando, Sergiu Sava, and Taimur Khan.
2025. "Impacts of Glucagon-like Peptide-1 Receptor-Agonist (GLP-1 RA) Treatment for Metabolic Disturbances and Weight Gain in Patients on Clozapine/Olanzapine: A Systematic Review" Obesities 5, no. 4: 72.
https://doi.org/10.3390/obesities5040072
APA Style
Varshney, K., Panda, S., Fernando, H., Sava, S., & Khan, T.
(2025). Impacts of Glucagon-like Peptide-1 Receptor-Agonist (GLP-1 RA) Treatment for Metabolic Disturbances and Weight Gain in Patients on Clozapine/Olanzapine: A Systematic Review. Obesities, 5(4), 72.
https://doi.org/10.3390/obesities5040072